LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4288 | 4267 | 1.0052 | 1.0057 |
MCF7 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4166 | 4056 | 1.0273 | 1.0317 |
MCF7 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3935 | 4267 | 0.9227 | 0.9120 |
MCF7 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3305 | 4056 | 0.8160 | 0.7755 |
MCF7 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2598 | 4267 | 0.6096 | 0.5160 |
MCF7 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2508 | 4056 | 0.6191 | 0.5115 |
MCF7 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1668 | 4267 | 0.3908 | 0.1821 |
MCF7 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1706 | 4056 | 0.4209 | 0.2071 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1063 | 4267 | 0.2495 | -0.0803 |
MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1156 | 4056 | 0.2852 | -0.0380 |
MCF7 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1235 | 768 | 4267 | 0.1803 | -0.2331 |
MCF7 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1235 | 724 | 4056 | 0.1785 | -0.2680 |
MCF7 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3555 | 4267 | 0.8335 | 0.8063 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3502 | 4267 | 0.8212 | 0.7913 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3561 | 4267 | 0.8351 | 0.8084 |
MCF7 | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3667 | 4267 | 0.8596 | 0.8365 |
MCF7 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3966 | 4267 | 0.9283 | 0.9169 |
MCF7 | Brivanib | 10 | uM | LJP5 | 72 | hr | 1235 | 3638 | 4267 | 0.8515 | 0.8263 |
MCF7 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3565 | 4056 | 0.8789 | 0.8549 |
MCF7 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3240 | 4056 | 0.7996 | 0.7552 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3231 | 4056 | 0.7964 | 0.7514 |
MCF7 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2455 | 4056 | 0.6060 | 0.4928 |
MCF7 | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2493 | 4056 | 0.6151 | 0.5063 |
MCF7 | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 1235 | 1624 | 4056 | 0.4006 | 0.1714 |
MCF7 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4787 | 4056 | 1.1804 | 1.2033 |